Emami (531162) Resumen de Acciones
Emami Limited fabrica y comercializa productos personales y sanitarios en la India y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 3/6 |
| Crecimiento futuro | 2/6 |
| Rendimiento pasado | 3/6 |
| Salud financiera | 6/6 |
| Dividendos | 6/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en 531162 a partir de nuestros controles de riesgos.
531162 Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Emami Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | ₹397.05 |
| Máximo en las últimas 52 semanas | ₹634.65 |
| Mínimo de 52 semanas | ₹376.05 |
| Beta | 0.15 |
| Cambio en 1 mes | -1.67% |
| Variación en 3 meses | 0.72% |
| Cambio de 1 año | -30.82% |
| Variación en 3 años | -3.78% |
| Variación en 5 años | -29.21% |
| Variación desde la OPV | 16,855.89% |
Noticias y actualizaciones recientes
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).Recent updates
531162: May Board Meeting And Leadership Review Will Support Bullish Outlook
Analysts have trimmed their price target on Emami to ₹545 from about ₹637, citing refreshed assumptions around slightly higher discount rates, more moderate revenue growth, softer profit margins, and a lower future P/E multiple. What’s in the News for Emami Emami has scheduled a Board meeting on May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Trimmed Fair Value And Rich Future P/E Will Shape Measured Outlook
Analysts have trimmed their price target on Emami from ₹425.00 to ₹415.00, reflecting updates to their models that now factor in different assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Rentabilidad de los accionistas
| 531162 | IN Personal Products | Mercado IN | |
|---|---|---|---|
| 7D | -0.8% | -1.0% | -0.5% |
| 1Y | -30.8% | -6.8% | -1.8% |
Rentabilidad vs. Industria: Los resultados de 531162 fueron inferiores a los de la industria Indian Personal Products, que obtuvo un rendimiento del -6.8% el año pasado.
Rentabilidad vs. Mercado: 531162 obtuvo unos resultados inferiores a los del mercado Indian, que fueron del -1.8% el año pasado.
Volatilidad de los precios
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.1% |
| Personal Products Industry Average Movement | 6.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.4% |
Precio estable de las acciones: 531162 no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado Indian.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 531162 (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited fabrica y comercializa productos personales y sanitarios en la India y a escala internacional. Ofrece crema antiséptica ayurvédica, polvo de calor espinoso, loción corporal doodh kesar, loción de aloe neem, vasocare vaselina de hierbas, aceite de coco, gel de aloe vera y productos de higiene bajo la marca Boroplus; aceite fresco, extra thanda, aceite ayurvédico de oro, aceite ayurvédico terapéutico para masajes corporales y alivio del estrés, talco fresco maxx y talco fresco bajo la marca Navratna; y bálsamo, bálsamo ultra-power, roll-on de alivio rápido, aceite ortomédico, pomada, gel y spray de alivio, productos de higiene, pancharishta, nityam y kesari jivan bajo la marca Zandu. La empresa también ofrece crema radiante y lavado facial radiante instantáneo para hombres bajo la marca Fair and Handsome; productos para el cuidado del cabello y champú bajo la marca Kesh King; bálsamo bajo la marca Mentho Plus; polvos contra la fiebre miliar bajo la marca Dermicool; aceite capilar, champús y acondicionadores bajo la marca Emami 7 Oils in One; desodorantes bajo la marca HE; tintes capilares con la marca Emami Diamond Shine; talco con la marca Emami Golden Beauty; crema facial a base de plantas con la marca Emami Naturally Fair; dentífrico con la marca Ayucare; tintes y aceites capilares con la marca Emami Gold; y cremas hidratantes, lociones, cremas suaves, cremas y aceites de glicerina, vaselina, champús para bebés y otros productos para la piel con la marca Cream21.
Resumen de fundamentos de Emami Limited
| Estadísticas fundamentales de 531162 | |
|---|---|
| Capitalización bursátil | ₹173.31b |
| Beneficios(TTM) | ₹7.75b |
| Ingresos (TTM) | ₹37.80b |
¿Está 531162 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 531162 | |
|---|---|
| Ingresos | ₹37.80b |
| Coste de los ingresos | ₹11.38b |
| Beneficio bruto | ₹26.42b |
| Otros gastos | ₹18.66b |
| Beneficios | ₹7.75b |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 17.76 |
| Margen bruto | 69.89% |
| Margen de beneficio neto | 20.51% |
| Ratio deuda/patrimonio | 4.2% |
¿Cómo se ha desempeñado 531162 a largo plazo?
Ver rendimiento histórico y comparativaDividendos
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/25 08:50 |
| Precio de las acciones al final del día | 2026/06/25 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2026/03/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Emami Limited está cubierta por 44 analistas. 20 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |